Aug 2026 · PPT
Source: Bse
Chemicals stocks · Micro cap · NSE
Laxmi Organic Industries Limited manufactures specialty chemicals and intermediates, including diketene derivatives and acetyl intermediates, servicing pharma, agro, pigments, coatings, and packaging industries globally.
SMA20 +3.9% / mo · MACD − · sector -5.7pp vs Nifty 500 (3M)
Latest FPI flow is positive, but a second consecutive positive fortnight is still required. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +39.7% · PAT +223.8% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +40% YoY · PAT +224% YoY · margin expansion · +32% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹968 Cr | +39.7% | +31.7% |
| EBITDA | ₹114 Cr | +267.7% | +111.1% |
| Operating margin | 12.0% | +760 bps | +500 bps |
| PAT | ₹68 Cr | +223.8% | +209.1% |
| PAT margin | 7.0% | +399 bps | +403 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 22/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term uptrend intact. RSI 39. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 27 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +2 points.
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q1 FY27 revenue grew 40% YoY and 32% QoQ to INR9,683 million, driven by a 10% volume growth, higher price realizations, and procurement efficiencies amidst raw material volatility.
The investment thesis remains intact. Scale benefits, end-to-end integration, and robust demand drove strong Q1 performance. Essentials EBITDA improved significantly, and the Dahej specialty project is nearing completion for a Q4 ramp-up.
Latest issuer-disclosed distribution across 2 reported categories.
Dahej Phase 2 capex is nearing completion, doubling diketene derivatives capability with commercialization and customer qualification targeted for Q3/Q4.
Company holds first-mover advantage in India with a robust new product development pipeline leveraging electrochemical fluorination technology.
Global economies of scale and end-to-end integration enable the company to capture upcycle benefits and secure customer requirements.
85% of Phase 2 capex will be capitalized in Q2, with mechanical completion in Q3, customer qualification in Q3, and ramp-up in Q4.
World-scale ethyl acetate capacity at the Lote site was successfully commissioned and is currently being deployed into the market.
Ongoing capacity restructuring, realignments, and shutdowns in Europe, Japan, and Korea benefit large players with economies of scale.
Positive demand momentum observed in industrial solutions, coatings, and newer-age industries serviced by the company.
Geopolitical uncertainties, West Asia crises, Red Sea bottlenecks, and a South China typhoon created logistics disruptions and feedstock price spikes.
Downstream pigment sites experienced certain softness, and feedstock volatility made buyers cautious with purchasing behavior.
Net working capital increased during the quarter due to strategic inventory procurement to secure raw material availability amidst volatility.
Essentials segment margins are subject to wide cyclical swings depending on daily and weekly raw material spread settlements.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Year-over-year comparison captures cyclical recovery and price realization trends, while quarter-on-quarter comparison reflects sequential momentum, spread changes, and project execution milestones.
Enterprise-level volume growth stood at around 10% for Q1 FY27, supported by double-digit volume growth in the Essentials segment.
Ethyl acetate spreads in March and April were higher than the 12-year average range of $215-$220 per ton, driven by raw material price spikes.
World-scale ethyl acetate capacity at Lote has been commissioned, and Dahej Phase 2 capex is nearing completion for upcoming commercialization.
Management expects net working capital to normalize over time as volatile operating conditions stabilize.
Term debt has peaked at approximately INR6,100 million with the nearing completion of the Dahej capex cycle, maintaining a net debt-to-equity of 0.3x.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Dahej Phase 2 Commissioning | Mechanical completion expected in early Q3 | Customer qualification in Q3 and commercial ramp-up in Q4 FY27 |
| Essentials Segment EBITDA Margins | Delivered 11% to 12% in Q1 FY27 | Sustainability over the cycle against historical mid single-digit averages |
| Net Debt and Working Capital | Term debt peaked at INR6,100 million; net D/E at 0.3x | Working capital normalization and commencement of debt repayments next year |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 38th percentile of the scored universe and 23rd percentile within Chemicals. Main check: financial discipline is weak at 30/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Chemicals: 23rd pctile, median 73 · Micro: 21st pctile, median 73
90 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse